KRYS
KRYS
US5011471027
Krystal Biotech, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 389.130.000 290.515.000
33.9%
Cost of Revenue 23.049.000 20.061.000
14.9%
Gross Profit 366.081.000 270.454.000
35.4%
204.786.000 167.206.000
22.5%
Operating Income 161.295.000 103.248.000
56.2%
Pretax Income 189.471.000 95.356.000
98.7%
Net Income Common Stockholders 204.831.000 89.159.000
129.7%
-- --
--
-- --
--
ende